These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 23897285)

  • 41. Immunosuppressives and biologics during pregnancy and lactation : A consensus report issued by the Austrian Societies of Gastroenterology and Hepatology and Rheumatology and Rehabilitation.
    Puchner A; Gröchenig HP; Sautner J; Helmy-Bader Y; Juch H; Reinisch S; Högenauer C; Koch R; Hermann J; Studnicka-Benke A; Weger W; Puchner R; Dejaco C
    Wien Klin Wochenschr; 2019 Jan; 131(1-2):29-44. PubMed ID: 30643992
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Management of inflammatory bowel disease.
    Botoman VA; Bonner GF; Botoman DA
    Am Fam Physician; 1998 Jan; 57(1):57-68, 71-2. PubMed ID: 9447214
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Management of inflammatory bowel disease in the pregnant patient.
    Habal FM; Ravindran NC
    World J Gastroenterol; 2008 Mar; 14(9):1326-32. PubMed ID: 18322943
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reproductive wish represents an important factor influencing therapeutic strategy in inflammatory bowel diseases.
    Zelinkova Z; Mensink PB; Dees J; Kuipers EJ; van der Woude CJ
    Scand J Gastroenterol; 2010; 45(1):46-50. PubMed ID: 19883275
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Drug insight: aminosalicylates for the treatment of IBD.
    Nielsen OH; Munck LK
    Nat Clin Pract Gastroenterol Hepatol; 2007 Mar; 4(3):160-70. PubMed ID: 17339853
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Updates in the management of inflammatory bowel disease during pregnancy.
    Bell SJ; Flanagan EK
    Med J Aust; 2019 Apr; 210(6):276-280. PubMed ID: 30905081
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical utilization of atypical antipsychotics in pregnancy and lactation.
    Gentile S
    Ann Pharmacother; 2004; 38(7-8):1265-71. PubMed ID: 15150376
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risk of ischaemic heart disease in patients with inflammatory bowel disease: a nationwide Danish cohort study.
    Rungoe C; Basit S; Ranthe MF; Wohlfahrt J; Langholz E; Jess T
    Gut; 2013 May; 62(5):689-94. PubMed ID: 22961677
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Update on pregnancy and breastfeeding in the era of biologics.
    Yarur A; Kane SV
    Dig Liver Dis; 2013 Oct; 45(10):787-94. PubMed ID: 23474350
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The fetal safety of thiopurines for the treatment of inflammatory bowel disease in pregnancy.
    Hutson JR; Matlow JN; Moretti ME; Koren G
    J Obstet Gynaecol; 2013 Jan; 33(1):1-8. PubMed ID: 23259868
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fecundity, pregnancy outcomes, and breastfeeding in patients with inflammatory bowel disease: a large cohort survey.
    Mañosa M; Navarro-Llavat M; Marín L; Zabana Y; Cabré E; Domènech E
    Scand J Gastroenterol; 2013 Apr; 48(4):427-32. PubMed ID: 23477328
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inflammatory bowel disease and preterm delivery.
    Wispelwey BP; Sheiner E
    Arch Gynecol Obstet; 2013 Oct; 288(4):725-30. PubMed ID: 23934241
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Thiopurines prevent advanced colorectal neoplasia in patients with inflammatory bowel disease.
    van Schaik FD; van Oijen MG; Smeets HM; van der Heijden GJ; Siersema PD; Oldenburg B
    Gut; 2012 Feb; 61(2):235-40. PubMed ID: 21602529
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Pregnancy and inflammatory bowel disease].
    Asimakopoulos G
    Rev Med Chir Soc Med Nat Iasi; 2004; 108(1):46-50. PubMed ID: 15688755
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Safety of high doses of mesalazine during pregnancy.
    Marteau P; Seksik P; Couve S; Jian R
    Am J Gastroenterol; 2005 Aug; 100(8):1897-8. PubMed ID: 16086733
    [No Abstract]   [Full Text] [Related]  

  • 57. [Inflammatory bowel disease and pregnancy].
    Duvnjak M; Lerotić I; Tomasić V; Pavić T; Virović L
    Lijec Vjesn; 2006; 128(1-2):48-55. PubMed ID: 16640228
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Safety of anti-TNF agents during pregnancy and breastfeeding in women with inflammatory bowel disease.
    Gisbert JP; Chaparro M
    Am J Gastroenterol; 2013 Sep; 108(9):1426-38. PubMed ID: 23752881
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pregnancy and inflammatory bowel disease.
    Mahadevan U
    Gastroenterol Clin North Am; 2009 Dec; 38(4):629-49. PubMed ID: 19913206
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inflammatory Bowel Disease and Reproductive Health: From Fertility to Pregnancy-A Narrative Review.
    Ronchetti C; Cirillo F; Di Segni N; Cristodoro M; Busnelli A; Levi-Setti PE
    Nutrients; 2022 Apr; 14(8):. PubMed ID: 35458153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.